semaglutide hyponatremia Lower doses of the GLP-1 agonist medication as effective as higher ones, Danish study finds Hyponatremia – International Emergency Medicine

In Zepbound clinical trials, patients lost an average of 20% of their body weight.* Learn more about potential side effects Zepbound is a dual-action GLP-1/GIP medication called tirzepatide that may be prescribed for weight loss, if appropriate

Most people tolerate semaglutide well, but side effects can show up, especially early on

The results showed a statistically significant association between tirzepatide and the composite outcome of gallbladder or biliary diseases, with a relative risk of 1.97 and a 95% confidence interval of 1.14 to 3.42

Protein protects your muscle mass, keeps your energy steady, and ensures your body gets the nutrients it needs to feel strong and supported

Combining these side-effect profiles without medical oversight increases the complexity of managing any adverse events that arise

Press and release the medicine for 5-10 seconds